Tamoxifen and raloxifene are liquid medications for breast cancer.
Tamoxifen is one of three drugs in an anti-angiogenetic protocol developed by Dr
 The effects of tamoxifen on breast cancer Ki-67 expression, sex hormone-binding globulin (SHBG) levels, and IGF-1 levels are dose-dependent across a dosage range of 1 to 20 mg/day in women with breast cancer

